Health-tech startup Tricog has partnered with AstraZeneca India to roll out a programme called ‘Project Heartbeat’. This program is focused on early and accurate diagnosis of heart attack patients, to reduce mortality rates among the patients.
The project focuses on the needs for an early diagnosis and intervention for patients who will be suspected of heart attack by enabling a cloud-based artificial intelligence supported interpretation of electrocardiograms (ECGs) and routing patients to the nearest fibrinolysis centres or Cath Labs.
This initiative aims to upskill the technicians and physicians at the primary and secondary care centres in the country to better manage heart attack patients by following the particular guidelines recommended in Acute Coronary Syndrome treatment protocols.
AstraZeneca India Managing Director Gagan Singh Bedi said, "With regards to heart attacks and its treatment, early diagnosis and timely treatment is the key. As the young population is also prone to heart attack these days, it is vital that we arrange facilities for early diagnosis and treatment in rural parts of the country, as they don’t have easy access to modern healthcare facilities."
Presently, the ‘Project Heartbeat’ has eight major hubs with all facilities to treat heart attack patients in India. They include Sanjeevan Medical Centre, B.K.L. Walawalkar Rural Medical College and Lifeline hospital in Maharashtra, Spandan hospital in Madhya Pradesh, Metro Heart in Delhi-NCR, and the CKS hospital in Rajasthan.
Bedi said that till now, this initiative has already come in contact with the lives of 13,000 patients.